Asthma drug dosing study pulled before starting
NCT ID NCT04973345
First seen Jan 31, 2026 · Last updated May 14, 2026 · Updated 16 times
Summary
This study was designed to find the best way to give the asthma drug terbutaline sulfate, comparing injection under the skin versus into a vein. Researchers planned to enroll adults with asthma to measure how the drug moves in the body and how well it improves breathing. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado
Aurora, Colorado, 80045, United States
-
University of Vermont
Burlington, Vermont, 05401, United States
Conditions
Explore the condition pages connected to this study.